Ajanta Pharma gets nod for share buyback plan of up to Rs 286 crore

28 Dec 2021 Evaluate

Ajanta Pharma’s board has approved a share buyback plan of up to Rs 286 crore, wherein the drug maker will buy back shares at a maximum price of Rs 2,550 apiece. The total pay-out towards buyback of shares will be not exceeding Rs 356 crore, including a share buyback consideration not exceeding Rs 286 crore and tax not exceeding Rs 70 crore, on a proportionate basis through the tender offer process.

Ajanta Pharma is a specialty pharmaceutical company engaged in development, manufacturing and marketing of quality finished dosages.

Ajanta Pharma Share Price

2850.00 -3.10 (-0.11%)
08-Jan-2026 11:11 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1769.10
Dr. Reddys Lab 1227.95
Cipla 1465.15
Zydus Lifesciences 925.95
Lupin 2191.80
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×